Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
By M. Pule, B. Savoldo, G. Myers, C. Rossig, Heidi V. Russell, G. Dotti, M. H. Huls, E. Liu, Adrian P. Gee, Z. Mei and 6 more. Nature Medicine, 2008
1,211 citations recorded by the source corpus.
Subfields: Genetics, Neurology, Oncology
View Paper: https://www.semanticscholar.org/paper/eda89e4ca39982715d5ae1dbffdcd09c8d86ca11
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
In Oncology
Citations in the corpus
- Adoptive immunotherapy for cancer: harnessing the T cell response (2012, positive): “Gen mühendisliği bu tedaviye duyarlı tümör histolojilerinin çeşitliliğini büyük ölçüde arttırabilir; yeni literatürdeki birkaç örneği vermek gerekirse, bu çeşitlilik şimdilerde nörüblastom (77), sinovial hücre sarkomu (6), lösemi ve lenfoma (3, 5, 7) içermektedir.”
- CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients. (2011, methodology): “lation with OKT3 antibody or single cell cloning (3).”
- Cancer regression and neurologic toxicity following anti-MAGE-A3 TCR gene therapy (2013, neutral): “spleen, paratracheal 2–3+ , >70% Surgery, IFN, XRT, IL-2, Zanolimumab 79 5 PR (4) Seizures, coma, TRM”